R2* magnetic resonance imaging of the liver in patients with iron overload

Blood

Volumn 113, Issue 20, 2009, Pages 4853-4855

  Hankins, Jane S ^a   McCarville, M Beth ^a   Loeffler, Ralf B ^a   Smeltzer, Matthew P ^a   Onciu, Mihaela ^a   Hoffer, Fredric A ^a   Li, Chin Shang ^a   Wang, Winfred C ^a   Ware, Russell E ^a   Hillenbrand, Claudia M ^a  

^a ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FERRITIN;

ADOLESCENT; ADULT; ARTICLE; BETA THALASSEMIA; BONE MARROW DEPRESSION; CALIBRATION; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FERRITIN BLOOD LEVEL; HUMAN; HUMAN TISSUE; IRON OVERLOAD; LIVER BIOPSY; LIVER WEIGHT; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; R2 NUCLEAR MAGNETIC RESONANCE IMAGING; SCHOOL CHILD; SICKLE CELL ANEMIA; BIOPSY; BLOOD; COMPARATIVE STUDY; LIVER; METHODOLOGY; PATHOLOGY; RADIOGRAPHY; SINGLE BLIND PROCEDURE; STANDARD;

ADOLESCENT; ADULT; BIOPSY; CALIBRATION; CHILD; FEMALE; FERRITINS; HUMANS; IRON OVERLOAD; LIVER; MAGNETIC RESONANCE IMAGING; MALE; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 66549115170     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2008-12-191643     Document Type: Article

References (13)

1. Anderson LJ, Holden S, Davis B, et al. Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Eur Heart J. 2001;22:2171-2179. (Pubitemid 33139463)
2. St Pierre TG, Clark PR, Chua-Anusorn W, et al. Noninvasive measurement and imaging of liver iron concentrations using proton magnetic resonance. Blood. 2005;105:855-861. (Pubitemid 40070775)
3. Wood JC, Enriquez C, Ghugre N, et al. MRI R2 and R2* mapping accurately estimates hepatic iron concentration in transfusion-dependent thalassemia and sickle cell disease patients. Blood. 2005;106:1460-1465. (Pubitemid 41129616)
4. Ishak K, Baptista A, Bianchi L, et al. Histological grading and staging of chronic hepatitis. J Hepatol. 1995;22:696-699.
5. Yohai VJ. High breakdown point and high efficiency robust estimates for regression. Ann Stat. 1987;15:642-656.
6. Altman DG, Bland JM. Measurement in medicine: the analysis of method comparison studies. Statistician. 1983;32:307-317.
7. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet. 1986;1:307-310. (Pubitemid 16134762)
8. Linnet K, Bruunshuus I. HPLC with enzymatic detection as a candidate reference method for serum creatinine. Clin Chem. 1991;37:1669-1675. (Pubitemid 21892725)
9. Brittenham GM, Cohen AR, McLaren CE, et al. Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major. Am J Hematol. 1993;42:81-85.
10. Karam LB, Disco D, Jackson SM, et al. Liver biopsy results in patients with sickle cell disease on chronic transfusions: poor correlation with ferritin levels. Pediatr Blood Cancer. 2008;50:62-65. (Pubitemid 350234267)
11. Alustiza JM, Artetxe J, Castiella A, et al. MR quantification of hepatic iron concentration. Radiology. 2004;230:479-484.
12. Gandon Y, Olivie D, Guyader D, et al. Noninvasive assessment of hepatic iron stores by MRI. Lancet. 2004;363:357-362. (Pubitemid 38169542)
13. Robson MD, Gatehouse PD, Bydder M, Bydder GM. Magnetic resonance: an introduction to ultrashort TE (UTE) imaging. J Comput Assist Tomogr. 2003;27:825-846. (Pubitemid 37420776)